Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations - Sundar, Shyam; Mehta, Himanshu; Suresh, A. V.; Singh, Shri P.; Madhukar, Rai; Murray, Henry W. (Clinical infectious diseases, 2004)
Keywords: Adolescent; Adult; amphotericin B; Amphotericin B - adverse effects; Amphotericin B - therapeutic use; amphotericin B deoxycholate; Animals; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antifungal agents; Antiprotozoal Agents - adverse effects; Antiprotozoal Agents - therapeutic use; Biological and medical sciences; Child; Child, Preschool; Cost estimates; Deoxycholic Acid - adverse effects; Deoxycholic Acid - therapeutic use; Diseases; Dosage; Drug Combinations; Drug Costs; Female; Fever; Hemoglobins; Hospital Costs; Human protozoal diseases; Humans; India - epidemiology; Infant; Infectious diseases; Leishmania; Leishmaniasis, Visceral - drug therapy; Leishmaniasis, Visceral - epidemiology; Leshmaniasis; Lipids; Liposomes; Major Articles; Male; Medical cures; Medical sciences; Middle Aged; Parasites; Parasitic diseases; Pharmacology. Drug treatments; Phosphatidylcholines - adverse effects; Phosphatidylcholines - therapeutic use; Phosphatidylglycerols - adverse effects; Phosphatidylglycerols - therapeutic use; Protozoal diseases; Treatment Outcome; Visceral leishmaniasis; Bihar; Asia; India; Human; Protozoal disease; Costs; Relapse; Cure; Rate; Kala azar; Lipids; Leishmaniasis; Parasitosis; Complex lipid; Infection; Antiprotozoal agent; Antibiotic; Antifungal agent; Treatment; Amphotericin B; Polyenic compound; Health economy; Dosage form; Parasiticide; Indian; Public health; Comparative study